Home | All results_reference

[RDF data]
Results Reference #109

Resource URI: http://static.linkedct.org/resource/results_reference/109
linkedct:citation Baila L, Suciu S, Muus P, et al.: Assessment of two doses of infliximab in patients with low/intermediate risk IPSS myelodysplastic syndrome (MDS): an EORTC leukemia group (LG) randomized phase II trial (06023). [Abstract] Blood 110 (11): A-1456, 2007.
rdfs:label Results Reference #109
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00074074>
linkedct:results_reference_id 109 (xsd:int)
rdf:type linkedct:results_reference